Literature DB >> 392510

Distribution of active and inactive forms of endorphins in rat pituitary and brain.

S Zakarian, D Smyth.   

Abstract

The recent isolation and identification of alpha-N-acetyl forms of the C-Fragment of lipotropin (beta-endorphin, residues 61-91) and the C'-Fragment (residues 61-87) [Smyth, D.G., Massey, D.E., Zakarian, S. & Finnie, M. (1979) Nature (London) 279, 252-254] has led to a study of their distribution in the pituitary and brain of the rat. Regions were mapped by the method of immunofluorescent staining and the reactive peptides were determined by immunoassay after extraction, gel filtration, and ion exchange chromatography. The major immunoreactive peptides in both lobes of the pituitary were found to be C'-Fragment and N-acetyl C'-Fragment, which are weakly active or inactive as opiates; the C-Fragment and its N-acetyl derivative represented minor components. This indicates that in the rat the circulating "endorphins" released from pituitary would have little morphinomimetic activity. The same four immunoreactive peptides were observed in rat brain. In the hippocampus the C'-Fragment was the principal component in the midbrain there was more C-Fragment but C'-Fragment predominated; in the hypothalamus the C-Fragment was the major peptide, almost to the exclusion of the other peptides. The results demonstrate that the processing of lipotropin is under differential control in anatomically distinct regions of the central nervous system. The processing of lipotropin in the hypothalamus is directed specifically to the production of lipotropin C-Fragment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 392510      PMCID: PMC411775          DOI: 10.1073/pnas.76.11.5972

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Hormone--receptor interactions: [4-carboranylalanine, 5-leucine]-enkephalin as a structural probe for the opiate receptor.

Authors:  A Eberle; O Leukart; P Schiller; J L Fauchère; R Schwyzer
Journal:  FEBS Lett       Date:  1977-10-15       Impact factor: 4.124

2.  Analgesic activity of lipotropin C fragment depends on carboxyl terminal tetrapeptide.

Authors:  M J Geisow; J F Deakin; J O Dostrovsky; D G Smyth
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

3.  Presence of immunoassayable beta-lipotropin in bovine brain and spinal cord: lack of concordance with ACTH concentrations.

Authors:  D T Krieger; A Liotta; T Suda; M Palkovits; M J Brownstein
Journal:  Biochem Biophys Res Commun       Date:  1977-06-06       Impact factor: 3.575

4.  beta-Endorphin: structure-activity relationships in the guinea pig ileum and opiate receptor binding assays.

Authors:  B A Doneen; D Chung; D Yamashiro; P Y Law; H H Loh; C H Li
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

5.  Failure of hypophysectomy to alter brain content of opioid peptides (endorphins).

Authors:  A L Cheung; A Goldstein
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

6.  beta-Lipotropin is the major opioid-like peptide of human pituitary and rat pars distalis: lack of significant beta-endorphin.

Authors:  A S Liotta; T Suda; D T Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

7.  Coordinate synthesis of corticotropins and endorphins by mouse pituitary tumor cells.

Authors:  R E Mains; B A Eipper
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

8.  Steps involved in the processing of common precursor forms of adrenocorticotropin and endorphin in cultures of mouse pituitary cells.

Authors:  J L Roberts; M Phillips; P A Rosa; E Herbert
Journal:  Biochemistry       Date:  1978-08-22       Impact factor: 3.162

9.  Common precursor to corticotropins and endorphins.

Authors:  R E Mains; B A Eipper; N Ling
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

10.  Isolation and characterization of the opioid peptides from rat pituitary: beta-lipotropin.

Authors:  M Rubinstein; S Stein; L D Gerber; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  16 in total

1.  Isolation of enzyme cDNA clones by enzyme immunodetection assay: isolation of a peptide acetyltransferase.

Authors:  J H Eberwine; J D Barchas; W A Hewlett; C J Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

2.  Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

3.  Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of beta-endorphin.

Authors:  J F Deakin; J O Doströvsky; D G Smyth
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

Review 4.  Distribution of beta-endorphin-related peptides in rat pituitary and brain.

Authors:  S Zakarian; D G Smyth
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

5.  Beta-endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia.

Authors:  P Nicolas; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  beta-endorphin-(1-27) is an antagonist of beta-endorphin analgesia.

Authors:  R G Hammonds; P Nicolas; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

7.  Immunoreactive beta-endorphin and adrenocorticotropin in human cerebrospinal fluid.

Authors:  K Nakao; S Oki; I Tanaka; K Horii; Y Nakai; T Furui; M Fukushima; A Kuwayama; N Kageyama; H Imura
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

8.  Mineralocorticoid and glucocorticoid effects on 31,000- and 29,000-dalton proopiomelanocortin in rat anterior pituitary and neurointermediate lobe.

Authors:  B A Khalid; A T Lim; D R Fraillon; J W Funder
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors.

Authors:  T Meo; C Gramsch; R Inan; V Höllt; E Weber; A Herz; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

Review 10.  Signaling mechanisms of μ-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation.

Authors:  Min-Ho Nam; Woojin Won; Kyung-Seok Han; C Justin Lee
Journal:  Cell Mol Life Sci       Date:  2020-07-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.